BRAIN TUMOR, RECURRENT
Clinical trials for BRAIN TUMOR, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, RECURRENT trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain tumor drug delivered directly via pump shows promise in early trial
Disease control Recruiting nowThis early-stage study tests a method called convection-enhanced delivery (CED) to give the chemotherapy drug topotecan directly to recurrent brain tumors in people with a specific genetic mutation (IDH-mutant malignant glioma). A pump placed under the skin delivers the drug thro…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE1 • Sponsor: Jeffrey N. Bruce • Aim: Disease control
Last updated May 17, 2026 03:56 UTC
-
Sound waves plus drug may slow aggressive brain tumor return
Disease control Recruiting nowThis study tests whether adding focused ultrasound (NaviFUS) to the standard drug Avastin can help people with recurrent glioblastoma, a serious brain cancer. About 32 adults whose tumor has come back after prior treatment will be randomly assigned to get Avastin alone or Avastin…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New tile therapy for brain tumors under Real-World watch
Knowledge-focused Recruiting nowThis study is tracking 600 people with different types of brain tumors who receive GammaTile radiation therapy during surgery. The goal is to see how well the treatment works and how safe it is in everyday medical practice. Researchers will measure how long tumors stay away and h…
Matched conditions: BRAIN TUMOR, RECURRENT
Sponsor: GT Medical Technologies, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 04:00 UTC